Denver–(Business Wire)–Posterity Health, the only digital male fertility center of excellence offering personalized advice, educational resources and effective male fertility treatment, today announced an oversubscribed $7.5 million funding round led by early-stage venture capital fund Distributed Ventures. The funding reinforces the importance of evaluating male partners when a couple is having difficulty conceiving. The fresh capital will accelerate the company’s digital health platform and provide male fertility testing and treatment nationwide. This expansion has been clearly synchronized to take advantage of the new male fertility benefit that came into effect on January 1, 2023.
“This funding allows us to move one step further in our mission of providing male fertility healthcare to every couple trying to conceive,” said Pam Pure, CEO of Posterity Health. “Male fertility specialists are a scarce resource with about There are 200 fellowship-trained physicians. Additionally, men prefer assessment and treatment at home. The expanded Offspring Health network will double the number of genitourinologists using the platform and provide the convenience of face-to-face sessions when needed Nursing.”
Early data extracted from Posterity Health’s hormone management studies with its patients demonstrate the importance and power of aggressive treatment and validation of Posterity Health’s model of care. For example, data shows that almost 70 percent of men who receive hormone management therapy have improved sperm counts.
“The increasing demand for services and expertise unique to Posterity Health has made the Distributed Ventures funding an important part of our goal to support emerging health tech companies. We are proud to support Posterity Health’s mission to enable male fertility Shawn Ellis, managing partner at Mission Distributed Ventures, said: “At a time when these services are desperately needed, it makes it easier for people to access care while ending the stigma surrounding it. “By leading the investment in Posterity Health, we are investing in digital transformation technologies critical to increasing access to innovative and comprehensive healthcare.”
Posterity Health is pleased to welcome participation in this funding round from FCA Venture Partners and WVV Capital, both experienced digital healthcare investors with expertise in expanding Posterity Health’s position as a leader in male reproductive healthcare.
“This is a critical next step in fertility benefit coverage to pay for men’s care and encourage men’s evaluations. Posterity Health’s unique model makes it possible for couples across the country to access genitourinologists who are specially trained to identify and treat male fertility Doctor,” said Tom Hearne, a partner at FCA Venture Partners. “Comprehensive care, along with OBGYN support from Posterity Health, facilitates early and simultaneous assessment of both partners when a couple is having difficulty conceiving. Posterity Health products will help each couple find the best path to pregnancy.”
Posterity Health provides comprehensive male fertility services and offers Posterity Health care programs developed in conjunction with a Medical Advisory Board comprised of the country’s top male fertility leaders including Dr. Peter Schlegel, Professor James J Colt and Weill Cornell Dr. James Smith, Ph.D., Department of Urology, UCSF, Director of the Center for Male Reproductive Health at UCSF, and Dr. Stan Honig, Director of the Yale Center for Men’s Health.
The company’s digital health platform includes virtual visits, home diagnostics and in-person consultations to help assess and improve male patients’ fertility status. Services include baseline assessments, sperm preservation, semen analysis, abortion counseling, diagnostic workups, vasectomy and gender affirmation care.
About the health of future generations
Posterity Health offers a broad portfolio of technology-enabled male fertility services, including home diagnostics, virtual visits, and in-person consultations focused on improving male fertility. The company seeks to educate, engage and heal men, shift the burden of conception away from women and create a unified experience for couples.
Posterity Health is committed to making male fertility management a core part of men’s health. To learn more, visit www.posterityhealth.com.
About Distributed Venture Capital
Distributed Ventures is a seed-to-Series B focused fund investing in entrepreneurs as they transform the future of fintech, insurtech and digital health and wellbeing ventures. As former founders, investors and operators, the Distributed Ventures team provides in-depth subject matter and early-stage operational expertise to help companies succeed from day one. Distributed Ventures was born out of NFP Ventures, and its goal is to help entrepreneurs demonstrate product-market fit and accelerate business development through diversified distribution channels. For more information, visit distributedvc.com.
About FCA Venture Partners
FCA Venture Partners is a venture capital firm that invests in early-stage healthcare technology and technology-enabled healthcare delivery companies to improve patient care, reduce costs and increase efficiency. FCA manages over $100 million in funding and invests from Seed to Series B. FCA brings valuable healthcare insights, connections and board experience to portfolio companies to accelerate growth and build disruptive and sustainable businesses. Headquartered in Nashville, the center of healthcare innovation, with strategic networks in Charlotte and Winston-Salem, NC, the FCA team has a decades-long track record, including more than 60 investments in the rapidly changing healthcare industry .
